The Board of Directors, comprised of leading COPD experts, is GOLD’s main governing body. It encourages dissemination and adoption of the reports on COPD management through utilization of existing health care structures in individual countries and promotes international collaboration on COPD research.
Alvar G. Agusti, MD, Chair
Director, Institut Clínic del Tòrax
Hospital Clínic, Universitat de Barcelona
Villarroel 170
08036 Barcelona, Spain
Richard Beasley, MD
Director of the Medical Research Institute of New Zealand
Professor of Medicine at Victoria University Wellington
Bartolome R. Celli, MD
Brigham and Women's Hospital
Pulmonary Division
75 Francis Street, PBB Clinics 3
Boston, MA, 02115, USA
Rongchang Chen, MD
Guangzhou Institute of Respiratory Disease
(State Key Lab of Respiratory Disease & National Clinical Research Center for Respiratory Disease)
First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
Gerard Criner, MD
Division of Pulmonary and Critical Care Medicine
Department of Medicine
Temple University School of Medicine
Philadelphia, PA 19140 USA
Peter Frith, MD
Southern Respiratory Services
Repatriation General Hospital, Adelaide
South Australia, Australia
David Halpin, MD
Royal Devon and Exeter Hospital
Devon, United Kingdom
M. Victorina López Varela, MD
Cátedra de Neumología
Facultad de Medicina
Universidad de la República, Hospital Maciel
Montevideo, Uruguay
Kevin Mortimer MD
Liverpool School of Tropical Medicine
Liverpool, United Kingdom
Sundeep Salvi MD, PhD, FCCP, FRCP
Director, Chest Research Foundation
Marigold Complex
Kalyaninagar
Pune 411014, India
Claus Vogelmeier, MD
Director, Internal Medicine Clinic
University of Gießen and Marburg
School of Medicine
Standort Marburg Baldingerstraße
D-35043 Marburg, Germany
GOLD Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions: